Latest Articles
Major international collaboration first of its kind for NZ
9 December 2015
A major medical science collaboration between China’s Guangdong Province and the University of Auckland is the first of its type by a New Zealand university and will focus on advanced research in Biomedicine, Engineering Sciences, Innovation and Commercialisation.
read more
New collaboration between New Zealand and China in medical science
16 November 2015
A joint centre for medical research established between China and New Zealand is the first of its kind and will focus on leading-edge medical science to seek new treatments for diseases such as cancer.
read more
New study to identify genetic link with obesity and diabetes
1 September 2015
The largest ever study to identify genes that predispose New Zealanders to obesity and type-2 diabetes was announced today by the Maurice Wilkins Centre at the annual Queenstown Research Week.
read more
Leading chemistry researcher wins international award
7 August 2015
Distinguished Professor Margaret Brimble, a Maurice Wilkins Centre Principal Investigator from the University of Auckland, has been named as one of this year’s Distinguished Women in Chemistry or Chemical Engineering by the International Union of Pure and Applied Chemistry (...
read more
Otago’s international TB research efforts gain major support
3 August 2015
University of Otago researchers have been awarded $450,000 for research into the genetics of drug-resistant tuberculosis (TB) in Indonesia and Myanmar through the e-ASIA HRC Joint Research Programme announced by the Health Research Council of New Zealand on the 3rd August 20...
read more
MWC Affiliate Dr Francis Hunter wins international innovation prize
21 July 2015
Congratulations to Dr Francis Hunter, a postdoctoral fellow at the Auckland Cancer Society Research Centre, who was a member of the winning team in the 5th Merck Serono Innovation Cup program.
read more
Avalia Immunotherapies to advance immunotherapy technology
21 May 2015
An immunotherapy technology for treating cancer and other diseases, jointly developed by Victoria University of Wellington’s Ferrier Research Institute and the Malaghan Institute of Medical Research, has been patented and will be the initial focus of a newly-formed company, ...
read more
Human clinical trials planned for new anti-cancer compound
23 April 2015
After a decade of discovery and research, two University of Auckland medical oncology researchers along with their dedicated teams have developed a new anti-cancer compound that will advance to human phase two clinical trials. The co-inventors of the compound TH-4000, Dr Ada...
read more